Tilray Brands Q3 Earnings: Revenue Up, Net Loss Widens

Ticker: TLRY · Form: 10-Q · Filed: 2024-04-09T00:00:00.000Z

Sentiment: mixed

Topics: earnings, cannabis, financials, loss

TL;DR

Tilray Q3: Revenue $189.1M, but net loss $117.7M. Assets $1.2B, Liabilities $774M.

AI Summary

Tilray Brands, Inc. filed its 10-Q for the period ending February 29, 2024, reporting total assets of $1.198 billion and total liabilities of $774.03 million. The company's net revenue for the quarter was $189.1 million, with a net loss of $117.7 million. As of February 29, 2024, Tilray Brands had $16.43 million in cash and cash equivalents.

Why It Matters

This filing provides insight into Tilray Brands' financial performance in Q3 2024, highlighting revenue generation and profitability challenges.

Risk Assessment

Risk Level: medium — The company reported a significant net loss, indicating potential financial instability or ongoing investment phases.

Key Numbers

Key Players & Entities

FAQ

What was Tilray Brands' net revenue for the third quarter of fiscal year 2024?

Tilray Brands reported net revenue of $189.1 million for the quarter ended February 29, 2024.

What was the net loss for Tilray Brands in the reported quarter?

The company reported a net loss of $117.7 million for the quarter ended February 29, 2024.

What were Tilray Brands' total assets as of February 29, 2024?

As of February 29, 2024, Tilray Brands had total assets of $1.198 billion.

How much cash and cash equivalents did Tilray Brands have at the end of the quarter?

Tilray Brands had $16.43 million in cash and cash equivalents as of February 29, 2024.

What is the company's fiscal year end?

Tilray Brands' fiscal year ends on May 31.

From the Filing

0001437749-24-011541.txt : 20240409 0001437749-24-011541.hdr.sgml : 20240409 20240409170015 ACCESSION NUMBER: 0001437749-24-011541 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 131 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 24833409 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 10-Q 1 tlry20240112_10q.htm FORM 10-Q tlry20240112_10q.htm 0001731348 Tilray Brands, Inc. false --05-31 Q3 2023 0.0001 0.0001 1,198,000,000 1,198,000,000 774,028,053 774,028,053 656,655,455 656,655,455 0.0001 0.0001 10,000,000 10,000,000 0 0 0 0 0 0 20,652,315 16,431,876 5,744,302 4,660,046 6,209,000 6,209,000 72,653,364 36,388,651 15 15 15 0 0 100 0 0 8 0 0 3.50 0 0 60 0 0 1,000 0 2 7,000 500 7,434 7,500 7,000 500 66,000 66,000 3 3 10 10 November 30, 2025 November 30, 2025 25,000 25,000 1.00 1.00 5 5 15 15 181 181 July 31, 2033 July 31, 2033 25,000 25,000 1.00 1.00 5 5 15 15 196 196 July 31, 2033 July 31, 2033 1,250 1,250 1.50 1.50 5 5 10 10 12 12 August 31, 2026 August 31, 2026 3,750 3,750 1.50 1.50 5 5 20 20 23 23 August 31, 2026 August 31, 2026 5,000 5,000 2.15 2.15 5 5 250 250 December 31, 2023 December 31, 2023 1,200 1,200 4.26 4.26 1 1 100 100 December 31, 2023 December 31, 2023 1,500 1,500 2.00 2.00 5 5 94 94 April 30, 2025 April 30, 2025 3,500 3,500 4.59 4.59 5 5 52 52 August 31, 2028 August 31, 2028 22,635 22,635 1.5 1.5 10 10 57 57 October 31, 2030 October 31, 2030 90,000 90,000 5 5 875 875 1,750 1,750 June 30, 2028 June 30, 2028 June 30, 2028 5.20 5.20 5.25 5.25 5.00 5.00 5.20 5.20 4.00 4.00 4.00 5.25 5.25 5.00 5.00 0 5.95 1 1 774,028,053 0 0 20 644 8,059 9,630 24,517 29,766 110,000 20,000 7,000 7,000 2,800 27,500 19,950 0 4 6,000 103,401 5,651 1,817 27,107 120,568 — — — 4,181 50,710 — 151 1,365 16,528 13,493 42,681 — — — — 4 0 0 0 0 0 false false false false 0001731348 2023-06-01 2024-02-29 xbrli:shares 0001731348 2024-04-05 thunderdome:item iso4217:USD 0001731348 2024-02-29 0001731348 2023-05-31 iso4217:USD xbrli:shares 0001731348 2023-12-01 2024-02-29 0001731348 2022-12-01 2023-02-28 0001731348 2022-06-01 2023-02-28 0001731348 tlry:CommonStockAndPreferredStockMember 2022-05-31 0001731348 us-gaap:AdditionalPaidInCapitalMember 2022-05-31 0001731348 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-05-31 0001731348 us-gaap:RetainedEarningsMember 2022-05-31 0001731348 us-gaap:NoncontrollingInterestMember 2022-05-31 0001731348 2022-05-31 0001731348 tlry:CommonStockAndPreferredStockMember 2022-06-01 2022-08-31 0001731348 us-gaap:AdditionalPaidInCapitalMember 2022-06-01 2022-08-31 0001731348 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-01 2022-08-31 0001731348 us-gaap:RetainedEarningsMember 2022-06-01 2022-08-31 0001731348 us-gaap:NoncontrollingInterestMember 2022-06-01 2022-08-31 0001731348 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember tlry:CommonStockAndPreferredStockMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember us-gaap:AdditionalPaidInCapitalMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember us-gaap:RetainedEarningsMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember us-gaap:NoncontrollingInterestMember 2022-0

View on Read The Filing